Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
Condition(s):Major Depressive DisorderLast Updated:February 11, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:February 11, 2014Completed
Condition(s):Depressive Disorder, MajorLast Updated:December 18, 2013Completed
Condition(s):Generalized Anxiety DisorderLast Updated:December 18, 2013Completed
Condition(s):Binge Eating DisorderLast Updated:November 23, 2020Completed
Condition(s):Post-Traumatic Stress DisorderLast Updated:February 8, 2021Completed
Condition(s):Major Depressive DisorderLast Updated:January 29, 2014Completed
Condition(s):Major Depressive DisorderLast Updated:December 18, 2013Completed
Condition(s):Major Depressive DisorderLast Updated:April 1, 2014Completed
Condition(s):TBI; Major DepressionLast Updated:September 2, 2016Withdrawn
Condition(s):Major Depressive Disorder (MDDLast Updated:April 13, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.